Digital pathology in drug discovery and development: multisite integration.

Steven J Potts
Author Information
  1. Steven J Potts: Aperio Technologies, Inc., Vista, CA 92081, United States. spotts@aperio.com

Abstract

Digital pathology is an emerging technology that provides an image-based environment for managing and interpreting the information generated from a digitized glass slide, offering substantial improvements in pharmaceutical drug development across discovery, preclinical GLP pathology and oncology clinical trials. Digital pathology is transforming global pharmaceutical research by enabling data sharing to integrate dispersed pharma pathology labs around the world. This article reviews the stages of multisite digital pathology integration in large pharmaceutical companies, offering suggestions for success and highlighting challenges.

MeSH Term

Access to Information
Animals
Cooperative Behavior
Drug Discovery
Drug Industry
Humans
Image Interpretation, Computer-Assisted
Information Storage and Retrieval
International Cooperation
Pathology, Clinical
Pathology, Veterinary
Software
Systems Integration
Telepathology

Word Cloud

Created with Highcharts 10.0.0pathologyDigitalpharmaceuticalofferingdrugdiscoverymultisiteintegrationemergingtechnologyprovidesimage-basedenvironmentmanaginginterpretinginformationgenerateddigitizedglassslidesubstantialimprovementsdevelopmentacrosspreclinicalGLPoncologyclinicaltrialstransformingglobalresearchenablingdatasharingintegratedispersedpharmalabsaroundworldarticlereviewsstagesdigitallargecompaniessuggestionssuccesshighlightingchallengesdevelopment:

Similar Articles

Cited By (9)